Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors

The Centers for Medicare and Medicaid Services (CMS) Hospital Compare central line-associated bloodstream infection (CLABSI) data and private databases containing new-generation intravenous needleless connector (study NC) use at the hospital level were linked. The relative risk (RR) of CLABSI associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabak, Ying P., Johannes, Richard S., Sun, Xiaowu, Crosby, Cynthia T., Jarvis, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2016
Materias:
Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014545/
https://www.ncbi.nlm.nih.gov/pubmed/27598072
http://dx.doi.org/10.1097/NAN.0000000000000185
_version_ 1782452308816166912
author Tabak, Ying P.
Johannes, Richard S.
Sun, Xiaowu
Crosby, Cynthia T.
Jarvis, William R.
author_facet Tabak, Ying P.
Johannes, Richard S.
Sun, Xiaowu
Crosby, Cynthia T.
Jarvis, William R.
author_sort Tabak, Ying P.
collection PubMed
description The Centers for Medicare and Medicaid Services (CMS) Hospital Compare central line-associated bloodstream infection (CLABSI) data and private databases containing new-generation intravenous needleless connector (study NC) use at the hospital level were linked. The relative risk (RR) of CLABSI associated with the study NCs was estimated, adjusting for hospital characteristics. Among 3074 eligible hospitals in the 2013 CMS database, 758 (25%) hospitals used the study NCs. The study NC hospitals had a lower unadjusted CLABSI rate (1.03 vs 1.13 CLABSIs per 1000 central line days, P < .0001) compared with comparator hospitals. The adjusted RR for CLABSI was 0.94 (95% confidence interval: 0.86, 1.02; P = .11).
format Online
Article
Text
id pubmed-5014545
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-50145452016-09-12 Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors Tabak, Ying P. Johannes, Richard S. Sun, Xiaowu Crosby, Cynthia T. Jarvis, William R. J Infus Nurs Features The Centers for Medicare and Medicaid Services (CMS) Hospital Compare central line-associated bloodstream infection (CLABSI) data and private databases containing new-generation intravenous needleless connector (study NC) use at the hospital level were linked. The relative risk (RR) of CLABSI associated with the study NCs was estimated, adjusting for hospital characteristics. Among 3074 eligible hospitals in the 2013 CMS database, 758 (25%) hospitals used the study NCs. The study NC hospitals had a lower unadjusted CLABSI rate (1.03 vs 1.13 CLABSIs per 1000 central line days, P < .0001) compared with comparator hospitals. The adjusted RR for CLABSI was 0.94 (95% confidence interval: 0.86, 1.02; P = .11). Wolters Kluwer Health, Inc. 2016-07 2016-09-16 /pmc/articles/PMC5014545/ /pubmed/27598072 http://dx.doi.org/10.1097/NAN.0000000000000185 Text en © 2016 Infusion Nurses Society This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Features
Tabak, Ying P.
Johannes, Richard S.
Sun, Xiaowu
Crosby, Cynthia T.
Jarvis, William R.
Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title_full Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title_fullStr Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title_full_unstemmed Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title_short Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors
title_sort innovative use of existing public and private data sources for postmarketing surveillance of central line-associated bloodstream infections associated with intravenous needleless connectors
topic Features
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014545/
https://www.ncbi.nlm.nih.gov/pubmed/27598072
http://dx.doi.org/10.1097/NAN.0000000000000185
work_keys_str_mv AT tabakyingp innovativeuseofexistingpublicandprivatedatasourcesforpostmarketingsurveillanceofcentrallineassociatedbloodstreaminfectionsassociatedwithintravenousneedlelessconnectors
AT johannesrichards innovativeuseofexistingpublicandprivatedatasourcesforpostmarketingsurveillanceofcentrallineassociatedbloodstreaminfectionsassociatedwithintravenousneedlelessconnectors
AT sunxiaowu innovativeuseofexistingpublicandprivatedatasourcesforpostmarketingsurveillanceofcentrallineassociatedbloodstreaminfectionsassociatedwithintravenousneedlelessconnectors
AT crosbycynthiat innovativeuseofexistingpublicandprivatedatasourcesforpostmarketingsurveillanceofcentrallineassociatedbloodstreaminfectionsassociatedwithintravenousneedlelessconnectors
AT jarviswilliamr innovativeuseofexistingpublicandprivatedatasourcesforpostmarketingsurveillanceofcentrallineassociatedbloodstreaminfectionsassociatedwithintravenousneedlelessconnectors

Ejemplares similares